Your browser doesn't support javascript.
loading
Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.
Jacobson, Karen R; Barnard, Marinus; Kleinman, Mary B; Streicher, Elizabeth M; Ragan, Elizabeth J; White, Laura F; Shapira, Ofer; Dolby, Tania; Simpson, John; Scott, Lesley; Stevens, Wendy; van Helden, Paul D; Van Rie, Annelies; Warren, Robin M.
Afiliación
  • Jacobson KR; Section of Infectious Diseases, Boston University School of Medicine, Massachusetts.
  • Barnard M; National Health Laboratory Service, Cape Town, South Africa.
  • Kleinman MB; Infectious Disease Prevention and Health Services Bureau, Prevention and Health Promotion Administration, Maryland Department of Health and Mental Hygiene, Baltimore.
  • Streicher EM; Department of Science and Technology/National Research Foundation Centre of Excellence in Biomedical Tuberculosis Research/South Africa Medical Research Council for Molecular Biology and Human Genetics, Stellenbosch University, Tyberberg.
  • Ragan EJ; Section of Infectious Diseases, Boston University School of Medicine, Massachusetts.
  • White LF; Department of Biostatistics, Boston University School of Public Health.
  • Shapira O; Department of Cancer Biology, Dana-Farber Cancer Institute, Cambridge, Massachusetts.
  • Dolby T; National Health Laboratory Service, Cape Town, South Africa.
  • Simpson J; National Health Laboratory Service, Cape Town, South Africa.
  • Scott L; Department of Molecular Medicine and Haematology, School of Pathology, University of the Witwatersrand and National Health Laboratory Service, National Priority Program, Johannesburg, South Africa.
  • Stevens W; Department of Molecular Medicine and Haematology, School of Pathology, University of the Witwatersrand and National Health Laboratory Service, National Priority Program, Johannesburg, South Africa.
  • van Helden PD; Department of Science and Technology/National Research Foundation Centre of Excellence in Biomedical Tuberculosis Research/South Africa Medical Research Council for Molecular Biology and Human Genetics, Stellenbosch University, Tyberberg.
  • Van Rie A; Department of Epidemiology, University of North Carolina, Chapel Hill.
  • Warren RM; Department of Epidemiology and Social Medicine and Epidemiology for Global Health Institute, University of Antwerp, Belgium.
Clin Infect Dis ; 64(11): 1502-1508, 2017 Jun 01.
Article en En | MEDLINE | ID: mdl-28199520
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifampin / Pruebas de Sensibilidad Microbiana / Tuberculosis Resistente a Múltiples Medicamentos / Farmacorresistencia Bacteriana / Mycobacterium tuberculosis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifampin / Pruebas de Sensibilidad Microbiana / Tuberculosis Resistente a Múltiples Medicamentos / Farmacorresistencia Bacteriana / Mycobacterium tuberculosis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article